N-[(1R)-2-oxo-1-phenyl-2-[(2S)-2-[5-[13-[2-[[[(2R)-2-phenyl-2-(pyrimidine-4-carbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]ethyl]pyrimidine-4-carboxamide

C54H48N12O6 — CID 134270600

IUPACN-[(1R)-2-oxo-1-phenyl-2-[(2S)-2-[5-[13-[2-[[[(2R)-2-phenyl-2-(pyrimidine-4-carbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]ethyl]pyrimidine-4-carboxamide
SMILESCCCN(Cc1ncc(-c2cc3c4c(c2)OCc2cc(-c5cnc([C@@H]6CCCN6C(=O)[C@H](NC(=O)c6ccncn6)c6ccccc6)[nH]5)cc(c2-4)OC3)[nH]1)C(=O)[C@H](NC(=O)c1ccncn1)c1ccccc1
InChIInChI=1S/C54H48N12O6/c1-2-19-65(53(69)48(32-10-5-3-6-11-32)63-51(67)38-15-17-55-30-59-38)27-45-57-25-40(61-45)34-21-36-28-72-44-24-35(22-37-29-71-43(23-34)46(36)47(37)44)41-26-58-50(62-41)42-14-9-20-66(42)54(70)49(33-12-7-4-8-13-33)64-52(68)39-16-18-56-31-60-39/h3-8,10-13,15-18,21-26,30-31,42,48-49H,2,9,14,19-20,27-29H2,1H3,(H,57,61)(H,58,62)(H,63,67)(H,64,68)/t42-,48+,49+/m0/s1
InChIKeyRHXJCDQWJALAMP-FVKJYKRZSA-N
MW961.06 g/mol
LogP7.24
Rot. Bonds15

About N-[(1R)-2-oxo-1-phenyl-2-[(2S)-2-[5-[13-[2-[[[(2R)-2-phenyl-2-(pyrimidine-4-carbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]ethyl]pyrimidine-4-carboxamide

N-[(1R)-2-oxo-1-phenyl-2-[(2S)-2-[5-[13-[2-[[[(2R)-2-phenyl-2-(pyrimidine-4-carbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]ethyl]pyrimidine-4-carboxamide (PubChem CID 134270600) has the molecular formula C54H48N12O6 and a molecular weight of 961.06 g/mol. Its IUPAC name is N-[(1R)-2-oxo-1-phenyl-2-[(2S)-2-[5-[13-[2-[[[(2R)-2-phenyl-2-(pyrimidine-4-carbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]ethyl]pyrimidine-4-carboxamide.

Molecular Properties

Compound NameN-[(1R)-2-oxo-1-phenyl-2-[(2S)-2-[5-[13-[2-[[[(2R)-2-phenyl-2-(pyrimidine-4-carbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]ethyl]pyrimidine-4-carboxamide
PubChem CID134270600
Molecular FormulaC54H48N12O6
Molecular Weight961.06 g/mol
Exact Mass960.38
IUPAC NameN-[(1R)-2-oxo-1-phenyl-2-[(2S)-2-[5-[13-[2-[[[(2R)-2-phenyl-2-(pyrimidine-4-carbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]ethyl]pyrimidine-4-carboxamide
SMILESCCCN(Cc1ncc(-c2cc3c4c(c2)OCc2cc(-c5cnc([C@@H]6CCCN6C(=O)[C@H](NC(=O)c6ccncn6)c6ccccc6)[nH]5)cc(c2-4)OC3)[nH]1)C(=O)[C@H](NC(=O)c1ccncn1)c1ccccc1
InChIInChI=1S/C54H48N12O6/c1-2-19-65(53(69)48(32-10-5-3-6-11-32)63-51(67)38-15-17-55-30-59-38)27-45-57-25-40(61-45)34-21-36-28-72-44-24-35(22-37-29-71-43(23-34)46(36)47(37)44)41-26-58-50(62-41)42-14-9-20-66(42)54(70)49(33-12-7-4-8-13-33)64-52(68)39-16-18-56-31-60-39/h3-8,10-13,15-18,21-26,30-31,42,48-49H,2,9,14,19-20,27-29H2,1H3,(H,57,61)(H,58,62)(H,63,67)(H,64,68)/t42-,48+,49+/m0/s1
InChIKeyRHXJCDQWJALAMP-FVKJYKRZSA-N
XLogP7.24
TPSA226.20 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds15
Heavy Atoms72
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500961.06
LogP ≤ 57.24
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Analyze N-[(1R)-2-oxo-1-phenyl-2-[(2S)-2-[5-[13-[2-[[[(2R)-2-phenyl-2-(pyrimidine-4-carbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]ethyl]pyrimidine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(1R)-2-oxo-1-phenyl-2-[(2S)-2-[5-[13-[2-[[[(2R)-2-phenyl-2-(pyrimidine-4-carbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]ethyl]pyrimidine-4-carboxamide?
The IUPAC name of N-[(1R)-2-oxo-1-phenyl-2-[(2S)-2-[5-[13-[2-[[[(2R)-2-phenyl-2-(pyrimidine-4-carbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]ethyl]pyrimidine-4-carboxamide (CID 134270600) is N-[(1R)-2-oxo-1-phenyl-2-[(2S)-2-[5-[13-[2-[[[(2R)-2-phenyl-2-(pyrimidine-4-carbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]ethyl]pyrimidine-4-carboxamide.
What is the SMILES notation for N-[(1R)-2-oxo-1-phenyl-2-[(2S)-2-[5-[13-[2-[[[(2R)-2-phenyl-2-(pyrimidine-4-carbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]ethyl]pyrimidine-4-carboxamide?
The canonical SMILES for N-[(1R)-2-oxo-1-phenyl-2-[(2S)-2-[5-[13-[2-[[[(2R)-2-phenyl-2-(pyrimidine-4-carbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]ethyl]pyrimidine-4-carboxamide is CCCN(Cc1ncc(-c2cc3c4c(c2)OCc2cc(-c5cnc([C@@H]6CCCN6C(=O)[C@H](NC(=O)c6ccncn6)c6ccccc6)[nH]5)cc(c2-4)OC3)[nH]1)C(=O)[C@H](NC(=O)c1ccncn1)c1ccccc1.
What is the InChIKey of N-[(1R)-2-oxo-1-phenyl-2-[(2S)-2-[5-[13-[2-[[[(2R)-2-phenyl-2-(pyrimidine-4-carbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]ethyl]pyrimidine-4-carboxamide?
The InChIKey is RHXJCDQWJALAMP-FVKJYKRZSA-N. The full InChI is InChI=1S/C54H48N12O6/c1-2-19-65(53(69)48(32-10-5-3-6-11-32)63-51(67)38-15-17-55-30-59-38)27-45-57-25-40(61-45)34-21-36-28-72-44-24-35(22-37-29-71-43(23-34)46(36)47(37)44)41-26-58-50(62-41)42-14-9-20-66(42)54(70)49(33-12-7-4-8-13-33)64-52(68)39-16-18-56-31-60-39/h3-8,10-13,15-18,21-26,30-31,42,48-49H,2,9,14,19-20,27-29H2,1H3,(H,57,61)(H,58,62)(H,63,67)(H,64,68)/t42-,48+,49+/m0/s1.
What are the key properties of N-[(1R)-2-oxo-1-phenyl-2-[(2S)-2-[5-[13-[2-[[[(2R)-2-phenyl-2-(pyrimidine-4-carbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]ethyl]pyrimidine-4-carboxamide?
N-[(1R)-2-oxo-1-phenyl-2-[(2S)-2-[5-[13-[2-[[[(2R)-2-phenyl-2-(pyrimidine-4-carbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]ethyl]pyrimidine-4-carboxamide has a molecular weight of 961.06 g/mol, XLogP of 7.24, 15 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1R)-2-oxo-1-phenyl-2-[(2S)-2-[5-[13-[2-[[[(2R)-2-phenyl-2-(pyrimidine-4-carbonylamino)acetyl]-propylamino]methyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]ethyl]pyrimidine-4-carboxamide is sourced from PubChem (CID 134270600), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).